Ashley Sumrall, MD

Ashley Sumrall, MD, FACP, FASCO, discusses CAR T-cell therapies and BTK inhibitors in primary central nervous system lymphoma and the role they play.

Ashley Sumrall, MD, FACP, medical oncologist, section chief, Neuro-Oncology, clinical assistant professor, medicine, Atrium Health, Levine Cancer Institute, discusses the clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas.

Professional and personal satisfaction are both possible with a hybrid option that optimizes work-life balance.